Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database

Abstract

BackgroundData regarding hypertrophic obstructive cardiomyopathy (HOCM) patients undergoing noncardiac surgery is lacking. We sought to examine the perioperative outcomes of HOCM patients undergoing noncardiac surgery using a national database. MethodsWe used the National readmission database from 2016 to 2019. We identified HOCM, heart undergoing noncardiac surgery using ICD 10 codes. We examined hospital outcomes as well as 90 days readmission outcomes. ResultsWe identified 16,098 HOCM patients and 21,895,699 non-HOCM patients undergoing noncardiac surgery. The HOCM group had more comorbidities at baseline. After adjustment for major clinical predictors, the HOCM group experienced more in-hospital death, odds ratio (OR) 1.33 (1.216–1.47), P < 0.001, acute myocardial infarction (AMI), OR 1.18 (1.077–1.292), P < 0.001, acute heart failure odds ratio OR 1.3 to (1.220–1.431), P < 0.001, 90 days readmission OR 1.237 (1.069–1.432), P < 0.01, cardiogenic shock OR 2.094 (1.855–2.363), P < 0.001. Cardiac arrhythmia was the most common cause of readmission, out of the arrhythmias atrial fibrillation was the most prevalent. Acute heart failure was the most common complication of readmission. There was no difference in major adverse cardiovascular events (MACE), and AMI between both groups and readmission. ConclusionHOCM patients undergoing noncardiac surgery may be at increased risk of in-hospital and readmission events. Acute heart failure was the most common complication during index admission, while cardiac arrhythmias were the most common complication during readmission. More research is needed to address this patient population further.